Ñî¹óåú´«Ã½Ò•îl

Indian pharmaceutical firms have spent decades supplying American patients with affordable medicines. That dominance will be difficult to challenge, despite President Donald Trump’s threat to impose steep tariffs on imported generic drugs. (Juliana Liu, 8/23)

Is it OK to raise this issue? I don’t want to be a bother. (Allison Sweet Grant, 8/22)

During a recent shift in the emergency department, I helped care for a woman facing a suspected oncologic emergency. She had come to the hospital expecting a routine evaluation, but suddenly found herself confronting conversations about diagnoses that could fundamentally change her life. (Zain Khawaja, 8/24)

Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. (Lisa Jarvis, 8/21)

After nearly 40 years in clinical medicine, I retired in 2022. While I expected to feel a sense of freedom, quitting medicine brought me an unexpected sense of loss over the thought of decades of accumulated knowledge, experience, and judgment suddenly going to waste. (Benjamin I. Lee, 8/24)